Previous evidence indicated that elevated P4HA1 expression was related to poor prognosis in some solid cancers, such as pancreatic cancer, head and neck cancer, high-grade gliomas, breast cancer, prostate cancer, and oral cancer [16–20]. Here, P4HA1 is linked to familial pancreatic carcinoma.